Sr. Director, Assays & Platform Technologies

Who We Are:

Cell Signaling Technology (CST) is a different kind of life sciences company, one founded, owned, and run by active research scientists, with the highest standards of product and service quality, technological innovation, and scientific rigor for over 20 years. We consistently provide fellow scientists around the globe with best-in-class products and services to fuel their quests for discovery.

Helping researchers find new solutions is our main mission every day, but it's not our only mission. We're also dedicated to helping identify solutions to other problems facing our world. We believe that all businesses must be responsible and work in partnership with local communities, while seeking to minimize their environmental impact. That's why we joined 1% for the Planet as its first life science member, and have committed to achieving net-zero emissions by 2029.

The Role:

As the Sr. Director for Assay and Platform Technologies, you will define and execute the company’s collective immunoassay platform strategy, and support critical commercial and business development partnerships. Operating at the intersection of research, product development, and commercial execution, you will oversee portfolio leadership, guide cross-functional collaborations, and lead four immunoassay platform sub-teams to drive innovation from concept through commercial success.

Platform Strategy & Portfolio Leadership (35%)

• Responsible for strategic and operational objectives, work plans, budgets, and portfolio health metrics across the four sub-teams • Responsible for the development of innovative products and solutions configured for use in established and emerging immunoassay platforms. • Develop and implement the product development platform strategy across traditional and emerging immunoassays, single-cell analysis, spatial biology, and mass spectrometry-based proteomics; translate CST's strategy into platform-specific roadmaps. • Product pipeline governance: accountable for the integrity and strategic coherence of the immunoassays product portfolio. • Responsible for go/no-go recommendations on platform onboarding and resource allocation decisions. • Collaborates with product development groups (antibody & protein technologies, antibody discovery, application & validation groups, and the Custom Solutions team on strategic and operational objectives, work plans, and portfolio health metrics. • Resource and budget management: makes decisions on resourcing trade-offs across sub-teams and between R&D platform development and pre/post-sales scientific support activities. • Drives adoption of new assays and platforms to support pre/post-sales, publishing, and customer engagement in alignment with company’s R&D objectives, with priority focus in biotech, pharma, and CRO customer segments.